Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CRTN @ $1.18: NEWS!..Very strong growth.
http://finance.yahoo.com/news/cartesian-reports-continued-growth-network-130100696.html
CRTN: Back to back catalysts on tap.
CRTN looked solid on Thursday and likely will regain full Nasdaq compliance via a closing bid of $1.00 or more today,(Friday)..
That sets up CRTN for the Q4 & full year earnings report due the week of 2/6/17.
Most observers expect the report to confirm CRTNs return to solid profitability.
A respected poster here pointed out that CRTN traded in the $4.50 to $5.50 range when it was in profit mode.
The market has a way of keeping you humble but CRTN does look very good here.
Expect, a news release before the open on Monday in regard to Nasdaq compliance if all goes well into the Friday close.
Just a great setup, imo
GOVX: FireceBiotech on Geovax.
Link:
http://www.fiercebiotech.com/biotech/geovax-draws-a-bead-hep-b-therapeutic-vaccine-deal
FireceBiotech on Geovax.
Link:
http://www.fiercebiotech.com/biotech/geovax-draws-a-bead-hep-b-therapeutic-vaccine-deal
CRTN: On target for full Nasdaq compliance @ 4pm on Friday.
Without doubt a news release on Monday.
Set up beautifully for Q4 news on week of 2/6/17.
CRTN: On target for full Nasdaq compliance @ 4pm on Friday.
Without doubt a news release on Monday.
Set up beautifully for Q4 news on week of 2/6/17.
GOVX: Near .07 200DMA. tech breakout over .07
BIOL: FDA approved laser device on 1/11/17. No company PR yet.
Biolase received FDA 510(k) approval for its Epic Pro Laser.
BIOL has not put out news yet.
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K163128
http://phx.corporate-ir.net/phoenix.zhtml?c=69766&p=irol-newsArticle&ID=2225155
GOVX: 500,000 shares @ .065 = $32,500.
Totally nuts.
When GOVX hits .13 that investment will be worth $65,000.
.50 = $250,000
$ROKA @ $4.35.....$15.85 cash...1.64M float....Gonna go
ROKA @ $4.35..$15.85 cash..1.64M float.
GOVX @ .068. Near break of 200dma @ .07. Tiny 42M float
NLNK & Merck Ebola 100% effective vax developer, Dr. Thomas Monath now GeoVax Chairman. $3.2M market cap
GOVX @ .068. Near break of 200dma @ .07. Tiny 42M float
NLNK & Merck Ebola 100% effective vax developer, Dr. Thomas Monath now GeoVax Chairman. $3.2M market cap
GOVX @ .068...06 is 50dma. .07 is 200dma....eom
50dma is .06. 200dma is .07. GOVX Fed AIDS milestone $$ due.
CRTN @ $1.07: Day 8 today. Needs 2 more for FULL Nasdaq compliance.
Low floater & profitable Nasdaq company.
Trades over $4.50 when in profit mode.
Headed right back there.
NOTE: Company likely issues news release next Monday, before the open concerning return to full Nasdaq compliance. Nice catalyst headed into wekk of 2/6/17 Q4 Report, expected to be in the black.
CRTN @ $1.07: Day 8 today. Needs 2 more for FULL Nasdaq compliance.
Low floater & profitable Nasdaq company.
Trades over $4.50 when in profit mode.
Headed right back there.
NOTE: Company likely issues news release next Monday, before the open concerning return to full Nasdaq compliance. Nice catalyst headed into wekk of 2/6/17 Q4 Report, expected to be in the black.
CRTN @ $1.07: Day 8 today. Needs 2 more for FULL Nasdaq compliance.
Low floater & profitable Nasdaq company.
Trades over $4.50 when in profit mode.
Headed right back there.
NOTE: Company likely issues news release next Monday, before the open concerning return to full Nasdaq compliance. Important.
GOVX: Nice volume. Fed $$ for AIDS vax news due.
CEO stated human vaccinations for AIDS prevention start this month.
Nice news pending.
CRTN @ $1.11: Back in FULL Nasdaq compliance on Fri. @ 4pm. Major.
6M float & ONLY profitable Nasdaq company trading under $4.00
One of the big plays unfolding.
CRTN @ $1.11: Back in FULL Nasdaq compliance Fri. Major.
6M float & ONLY profitable Nasdaq company trading under $4.00
One of the big plays unfolding.
GOVX @ .06: MVA-VLP Vector Platform.
GOVX has made multiple deals recently with other big name research groups that want to incorporate the MVA-VLP Vector Platform into their programs.
It appears to be an ideal venue for virtually any vaccine candidate drug.
IMO, GOVX is a prime buyout candidate for may reasons, but the Platform itself is a big drawer in its own right.
Here is a snippit from todays news concerning this issue.
1-17-17:
"Therapeutic vaccine candidates will be based upon GeoVax's novel MVA-VLP vector platform, which has been proven safe in multiple human clinical trials of company's preventive HIV vaccine. This platform is also being used by GeoVax to develop preventive vaccines against Zika virus and hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa). GeoVax also recently initiated a collaborative project with The Burnet Institute to use its MVA-VLP platform to develop a vaccine to prevent malaria infection.
Link:
https://finance.yahoo.com/news/geovax-collaborate-georgia-state-university-140000368.html
GOVX: MVA-VLP Vector Platform.
GOVX has made multiple deals recently with other big name research groups that want to incorporate the MVA-VLP Vector Platform into their programs.
It appears to be an ideal venue for virtually any vaccine candidate drug.
IMO, GOVX is a prime buyout candidate for may reasons, but the Platform itself is a big drawer in its own right.
Here is a snippit from todays news concerning this issue.
1-17-17:
"Therapeutic vaccine candidates will be based upon GeoVax's novel MVA-VLP vector platform, which has been proven safe in multiple human clinical trials of company's preventive HIV vaccine. This platform is also being used by GeoVax to develop preventive vaccines against Zika virus and hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa). GeoVax also recently initiated a collaborative project with The Burnet Institute to use its MVA-VLP platform to develop a vaccine to prevent malaria infection.
Link:
https://finance.yahoo.com/news/geovax-collaborate-georgia-state-university-140000368.html
CRTN @ $1.10: Back in Nasdaq compliance Fri., 1/20 @ 4pm.
That will make 10 consecutive days over $1.00.
A news release will be posted on Monday morning 1/23/17
That will set low floater CRTN up for the expected positive Q4 news the week of 2/6/17.
CRTN is only profitable Nasdaq company trading under $3.00
6M float and closely held.
NOTE: If this board is strictly for bio/pharma please delete, and I will not post another non-bio/pharma again, and my apology in advance.
CRTN @ $1.10: Back in FULL Nasdaq compliance on Fri @ 4pm. News Monday.
Today is day 7 over $1.00.
CRTN needs 10 consecutive days over $1.00 to regain FULL Nasdaq compliance.
The market close @ 4pm makes 10 days.
So, expect a MAJOR news announcement from CRTN concerning Nasdaq next Monday morning at the open.
That is news that will move the stock higher.
NO doubt.
CRTN: Back in FULL Nasdaq compliance on Fri @ 4pm. News Monday.
Today is day 7 over $1.00.
CRTN needs 10 consecutive days over $1.00 to regain FULL Nasdaq compliance.
The market close @ 4pm makes 10 days.
So, expect a MAJOR news announcement from CRTN concerning Nasdaq next Monday morning at the open.
That is news that will move the stock higher.
NO doubt.
GOVX: Expansion news into China. MRK & NLNK @ same facility.
Looks like the genius developer of the 100% effective Ebola vaccine for Merck & NewLink did not wait long to help GeoVax crack into the China market.
Very nice indeed.
GOVX @ .06: Deal with Georgia State & Peking University on Hep-B.
First time, to my knowledge that GeoVax has made a deal in China.
Link:
https://finance.yahoo.com/news/geovax-collaborate-georgia-state-university-140000368.html
GOVX: NEWS: Deal with Georgia State & Peking University for Hep-B
See news.
China expansion big.
Link:
https://finance.yahoo.com/news/geovax-collaborate-georgia-state-university-140000368.html
CRTN: Needs 4 more days over $1.00 for FULL Nasdaq compliance. Fri. @ 4pm.
CRTN closed over $1.00 the last 6 trading days.
Needs 4 more to be back in full Nasdaq compliance.
That is very big news as CRTN heads into what most expect to be a 2/6/17 positive Q4 Earnings Report.
So, if it lines up for CRTN, investors can expect a news release next Monday morning announcing that CRTN is back in Nasdaq compliance.
Well worth putting CRTN up on the screen at the open for Tuesday.
Imo, each day CRTN gets closer to Friday @ 4pm, the interest level is going to rise.
Just a great catalyst heading into an even bigger one, the 2/6/17 Q4 news.
CRTN: Needs 4 more days over $1.00 for FULL Nasdaq compliance. Fri. @ 4pm.
CRTN closed over $1.00 the last 6 trading days.
Needs 4 more to be back in full Nasdaq compliance.
That is very big news as CRTN heads into what most expect to be a 2/6/17 positive Q4 Earnings Report.
So, if it lines up for CRTN, investors can expect a news release next Monday morning announcing that CRTN is back in Nasdaq compliance.
Well worth putting CRTN up on the screen at the open for Tuesday.
Imo, each day CRTN gets closer to Friday @ 4pm, the interest level is going to rise.
Just a great catalyst heading into an even bigger one, the 2/6/17 Q4 news.
CRTN @ $1.14: Low floater breaking out.
Low 6M float, almost all of it locked up.
Headed back to Nasdaq compliance next Thursday.....that will be 10 days trading over $1.00.
Then, the week of 2/6/17 comes Q4 Earnings which are expected to be very strong according to CEO interview.
CRTN trades at $4.50 to $5.5os when in profit mode and it has returned to strong profitability.
A true multi-bagger here.
Buy CRTN today.
Website:
http://www.cartesian.com/
CRTN @ $1.14: ONLY profitable Nasdaq co. under $4.00.
Low 6M float, almost all of it locked up.
Headed back to Nasdaq compliance next Thursday.....that will be 10 days trading over $1.00.
Then, the week of 2/6/17 comes Q4 Earnings which are expected to be very strong according to CEO interview.
CRTN trades at $4.50 to $5.5os when in profit mode and it has returned to strong profitability.
A true multi-bagger here.
Buy CRTN today.
Website:
http://www.cartesian.com/
CRTN @ $1.14: Only profitable Nasdaq co. under $4.00.
Low 6M float, almost all of it locked up.
Headed back to Nasdaq compliance next Thursday.....that will be 10 days trading over $1.00.
Then, the week of 2/6/17 comes Q4 Earnings which are expected to be very strong according to CEO interview.
CRTN trades at $4.50 to $5.5os when in profit mode and it has returned to strong profitability.
A true multi-bagger here.
Buy CRTN today.
Website:
http://www.cartesian.com/
CBIO @ .64. Bought more.
It was a good buy @ .68.
Should be a better buy now.......lol
CBIO:
Fridays are tough to get a monster move going, which I posted earlier concerning CBIO.
It hit .75 on strong out the gate volume but then got slammed.
The ingredients are there for a mover over $1.00. Maybe not today.
If it drops more, I may buy more.
CBIO @ .67: Big seller there.
1.5M shares so far in two days.
has all of the ingredients for a nice pop but someone else has other plans.
CBIO @ .75. Strong volume.
CBIO: On the radar.
A number of hot plays took a dip today.
Lots of cash looking for the next home run.
CBIO fits the profile.
May not be a big Friday but likely will run at some point.
Cheap share price. Low float and lots of cash.
Website:
http://www.catalystbiosciences.com/
Link:
http://finviz.com/quote.ashx?t=cbio